Published works
COVID-19
COVID-19
-
209
Urinary liver-type fatty acid binding protein is increased in the early stages of the disease with a risk of acute kidney injury induced by histone.
Nephrology (Carlton).2023
DOI: 10.1111/nep.14162 PubMed -
208
Urinary L-Type Fatty Acid-Binding Protein Predicts Oxygen Demand of COVID-19 in Initially Mild Cases.
Care Explor. 2023
doi: 10.1097/CCE.0000000000000873. PubMed - 204 Evaluation of Urine L-FABP Point of Care Kit in the Philippines as Predictive Marker of Clinical Severity of COVID-19 (EPOCH COVID study). Philipp J Intern Med. 2022 PJIM
-
192
Urine sediment findings were milder in patients with COVID-19-associated renal injuries than in those with non-COVID-19-associated renal injuries.
Int J Infect Dis. 2022
doi: 10.1016/j.ijid.2022.02.024. PubMed -
191
Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19.
J Clin Apher. 2021
doi: 10.1002/jca.21861. PubMed -
187
Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomes.
J Thromb Thrombolysis. 2022
doi: 10.1007/s11239-022-02631-7. PubMed -
172
First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19.
Open Forum Infect Dis. 2021
doi: 10.1093/ofid/ofab274. PubMed -
171
COVID-19-induced acute renal tubular injury associated with elevation of serum inflammatory cytokine.
Clin Exp Nephrol. 2021
doi: 10.1007/s10157-021-02101-z. PubMed -
155
Evaluation of Coronavirus Disease 2019 Severity Using Urine Biomarkers.
Crit Care Explor. 2020
doi: 10.1097/CCE.0000000000000170. PubMed